drugset / Trial / NCT00794885

China Stroke Primary Prevention Trial

NCT00794885

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this trial is to confirm that enalapril maleate and folic acid tablets is more effective in preventing stroke among the patients with primary hypertension when compared to enalapril maleate.

Timeline

Start
2008-05
Primary completion
2013-08
Completion
2014-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject folic acid Other / unclassified 0.8 mg Oral
Comparator Enalapril Other / unclassified 10 mg Oral